MEF2B and Miyoshi myopathy: A statistically significant reduction in ASF1B, CD82B, and CRISP3 gene expression was observed in the MM group compared to the NCBD group (p < 0.05) alongside a concurrent elevation in FN1, MEF2B, PD-L1, PPARγ, and TERT expression levels (Table S2).